Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN
· Real-Time Price · USD
3.15
-0.05 (-1.56%)
At close: Jun 17, 2025, 1:51 PM
-1.56% (1D)
| Bid | 3.08 |
| Market Cap | 33.97M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -19.88M |
| EPS (ttm) | -1.84 |
| PE Ratio (ttm) | -1.71 |
| Forward PE | -2.02 |
| Analyst | Buy |
| Ask | 3.29 |
| Volume | 18,777 |
| Avg. Volume (20D) | 51,988 |
| Open | 3.20 |
| Previous Close | 3.20 |
| Day's Range | 3.15 - 3.24 |
| 52-Week Range | 2.55 - 6.12 |
| Beta | 1.54 |
About LTRN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LTRN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LTRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+9.06%
LTRN stock has given up its prior gain. Lantern Ph...
Unlock content with
Pro Subscription
2 weeks ago
+9.06%
Lantern Pharma shares are trading higher after the company announced preclinical data for LP-184.
